The Ensign Group, Inc. (ENSG) P/E Ratio History
Fairly ValuedTrading at 26.3x, near 5Y avg of 26.7x · 60th percentile · In line with own history · Data 2007–2026
Loading P/E history...
P/E Ratio Analysis
As of June 22, 2026, The Ensign Group, Inc. (ENSG) trades at a price-to-earnings ratio of 26.3x, with a stock price of $153.65 and trailing twelve-month earnings per share of $6.10.
The current P/E is roughly in line with its 5-year average of 26.7x. Over the past five years, ENSG's P/E has ranged from a low of 20.5x to a high of 34.8x, placing the current valuation at the 60th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, ENSG trades at a 19% premium to its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 197.0x.
The PEG ratio of 1.91 (P/E divided by 14% EPS growth) suggests a fair valuation relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, ENSG trades roughly in line with the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ENSG DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ENSG Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
ENSG P/E vs Peers
Post-acute and senior care peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $3B | 26.3 | 1.14 | +17% | |
| $1B | 39.8 | 3.95 | +18% | |
| $2B | 18.1 | 0.90 | +23% | |
| $2B | 14.0 | - | -29% | |
| $9B | 6.1Lowest | 0.38Best | +37%Best | |
| $2B | 881.5 | - | -84% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
ENSG Historical P/E Data (2007–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $201.50 | $6.14 | 32.8x | +71% |
| FY2025 Q4 | Dec 31 2025 | $174.20 | $5.84 | 29.8x | +55% |
| FY2025 Q3 | - | $172.77 | $5.59 | 30.9x | +61% |
| FY2025 Q2 | Jun 30 2025 | $154.26 | $5.51 | 28.0x | +46% |
| FY2025 Q1 | Mar 31 2025 | $129.40 | $5.29 | 24.5x | +27% |
| FY2024 Q4 | - | $132.86 | $5.11 | 26.0x | +35% |
| FY2024 Q3 | Sep 30 2024 | $143.82 | $4.13 | 34.8x | +81% |
| FY2024 Q2 | Jun 30 2024 | $123.69 | $3.90 | 31.7x | +65% |
| FY2024 Q1 | Mar 31 2024 | $124.42 | $3.80 | 32.7x | +71% |
| FY2023 Q4 | Dec 31 2023 | $112.21 | $3.66 | 30.7x | +60% |
| FY2023 Q3 | Sep 30 2023 | $92.93 | $4.37 | 21.3x | +11% |
| FY2023 Q2 | Jun 30 2023 | $95.46 | $4.25 | 22.5x | +17% |
| FY2023 Q1 | Mar 31 2023 | $95.54 | $4.14 | 23.1x | +20% |
| FY2022 Q4 | Dec 31 2022 | $94.61 | $3.98 | 23.8x | +24% |
| FY2022 Q3 | Sep 30 2022 | $79.50 | $3.75 | 21.2x | +10% |
| FY2022 Q2 | - | $73.47 | $3.59 | 20.5x | +7% |
| FY2022 Q1 | - | $90.01 | $3.45 | 26.1x | +36% |
| FY2021 Q4 | Dec 31 2021 | $83.96 | $3.42 | 24.5x | +28% |
| FY2021 Q3 | - | $74.89 | $3.38 | 22.2x | +15% |
| FY2021 Q2 | Jun 30 2021 | $86.67 | $3.32 | 26.1x | +36% |
| FY2021 Q1 | Mar 31 2021 | $93.84 | $3.18 | 29.5x | +54% |
| FY2020 Q4 | - | $72.92 | $3.05 | 23.9x | +25% |
| FY2020 Q3 | Sep 30 2020 | $57.06 | $2.72 | 21.0x | +9% |
| FY2020 Q2 | - | $41.85 | $2.43 | 17.2x | -10% |
| FY2020 Q1 | - | $37.61 | $2.21 | 17.0x | -11% |
| FY2019 Q4 | - | $45.37 | $1.97 | 23.0x | +20% |
| FY2019 Q3 | Sep 30 2019 | $44.35 | $1.96 | 22.6x | +18% |
| FY2019 Q2 | Jun 30 2019 | $53.22 | $1.86 | 28.6x | +49% |
| FY2019 Q1 | Mar 31 2019 | $47.87 | $1.76 | 27.2x | +42% |
| FY2018 Q4 | Dec 31 2018 | $36.27 | $1.70 | 21.3x | +11% |
| FY2018 Q3 | Sep 30 2018 | $35.46 | $1.43 | 24.8x | +29% |
| FY2018 Q2 | Jun 30 2018 | $33.49 | $1.32 | 25.4x | +32% |
| FY2018 Q1 | Mar 31 2018 | $24.59 | $1.14 | 21.6x | +12% |
| FY2017 Q4 | Dec 31 2017 | $20.76 | $0.76 | 27.3x | +42% |
| FY2017 Q3 | Sep 30 2017 | $21.12 | $0.90 | 23.5x | +22% |
| FY2017 Q2 | Jun 30 2017 | $20.36 | $0.84 | 24.2x | +26% |
| FY2017 Q1 | Mar 31 2017 | $17.58 | $0.83 | 21.2x | +10% |
| FY2016 Q4 | Dec 31 2016 | $20.77 | $0.96 | 21.6x | +13% |
| FY2016 Q3 | Sep 30 2016 | $18.82 | $0.88 | 21.4x | +11% |
| FY2016 Q2 | - | $19.65 | $0.92 | 21.4x | +11% |
| FY2016 Q1 | - | $21.17 | $0.95 | 22.3x | +16% |
| FY2015 Q4 | - | $21.16 | $1.08 | 19.6x | +2% |
| FY2015 Q3 | Sep 30 2015 | $19.93 | $1.07 | 18.6x | -3% |
| FY2015 Q2 | - | $23.87 | $1.01 | 23.6x | +23% |
| FY2015 Q1 | - | $21.91 | $0.81 | 27.2x | +42% |
| FY2014 Q4 | Dec 31 2014 | $20.75 | $0.80 | 26.1x | +36% |
| FY2014 Q3 | - | $16.27 | $0.83 | 19.5x | +2% |
| FY2014 Q2 | Jun 30 2014 | $14.53 | $0.89 | 16.4x | -14% |
| FY2014 Q1 | Mar 31 2014 | $11.55 | $1.12 | 10.3x | -46% |
| FY2013 Q4 | - | $11.72 | $0.54 | 21.7x | +13% |
| FY2013 Q3 | Sep 30 2013 | $10.88 | $0.28 | 38.2x | +99% |
| FY2013 Q2 | Jun 30 2013 | $9.32 | $0.34 | 27.0x | +41% |
| FY2013 Q1 | Mar 31 2013 | $8.84 | $0.34 | 25.6x | +33% |
| FY2012 Q4 | Dec 31 2012 | $7.19 | $0.93 | 7.8x | -60% |
| FY2012 Q3 | Sep 30 2012 | $8.10 | $1.13 | 7.2x | -63% |
| FY2012 Q2 | Jun 30 2012 | $7.48 | $1.10 | 6.8x | -65% |
| FY2012 Q1 | Mar 31 2012 | $7.19 | $1.12 | 6.4x | -67% |
| FY2011 Q4 | Dec 31 2011 | $6.48 | $1.12 | 5.8x | -70% |
| FY2011 Q3 | Sep 30 2011 | $6.12 | $1.15 | 5.3x | -72% |
| FY2011 Q2 | - | $8.04 | $1.12 | 7.2x | -63% |
| FY2011 Q1 | - | $8.45 | $1.05 | 8.0x | -58% |
| FY2010 Q4 | Dec 31 2010 | $6.58 | $0.97 | 6.8x | -65% |
| FY2010 Q3 | - | $4.75 | $0.90 | 5.3x | -73% |
| FY2010 Q2 | Jun 30 2010 | $4.37 | $0.85 | 5.1x | -73% |
| FY2010 Q1 | Mar 31 2010 | $4.57 | $0.82 | 5.6x | -71% |
| FY2009 Q4 | - | $4.07 | $0.79 | 5.2x | -73% |
| FY2009 Q3 | Sep 30 2009 | $3.71 | $0.77 | 4.8x | -75% |
| FY2009 Q2 | - | $3.77 | $0.75 | 5.0x | -74% |
| FY2009 Q1 | - | $4.09 | $0.71 | 5.8x | -70% |
| FY2008 Q4 | Dec 31 2008 | $4.43 | $0.68 | 6.5x | -66% |
| FY2008 Q3 | - | $4.52 | $0.64 | 7.1x | -63% |
| FY2008 Q2 | Jun 30 2008 | $3.04 | $0.60 | 5.1x | -74% |
| FY2008 Q1 | Mar 31 2008 | $2.45 | $0.61 | 4.0x | -79% |
| FY2007 Q4 | Dec 31 2007 | $3.81 | $0.57 | 6.7x | -65% |
Average P/E for displayed period: 19.2x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
19+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ENSG — Frequently Asked Questions
Quick answers to the most common questions about buying ENSG stock.
What is ENSG's P/E ratio?
The Ensign Group, Inc. (ENSG) trailing twelve-month P/E ratio is 26.3x, based on TTM diluted EPS of $6.10. The 5-year average P/E is 26.7x and the historical range spans 20.5x to 34.8x.
Is ENSG stock overvalued or undervalued?
ENSG trades at 26.3x P/E, near its 5-year average of 26.7x. The 60th percentile ranking within the 20.5x–34.8x historical range places valuation within normal bounds.
Is ENSG stock expensive?
ENSG is fairly valued relative to its own history. The current P/E of 26.3x is near the 5-year average of 26.7x (60th percentile of historical range).
What is ENSG's historical P/E range?
Over the past 5 years, ENSG's P/E ratio has ranged from 20.5x to 34.8x, with a median of 26.1x and an average of 26.7x. The current P/E of 26.3x places the stock at the 60th percentile of this range. Full historical data spans 2007–2026.
How does ENSG's P/E compare to the S&P 500?
ENSG trades at 26.3x P/E versus the S&P 500 median of 24.4x. The 8% premium to the market typically reflects higher expected earnings growth or quality.
How does ENSG's valuation compare to Healthcare peers?
The Ensign Group, Inc. P/E of 26.3x compares to the Healthcare sector median of 22.1x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is ENSG's PEG ratio?
ENSG PEG ratio is 1.91, based on a P/E of 26.3x and EPS growth of 14.1%. A PEG between 1 and 2 suggests valuation aligns with growth expectations — typically considered fair.
What is ENSG's earnings yield?
ENSG earnings yield is 3.80%, the inverse of its 26.3x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.